Alcon is the global leader in eye care, dedicated to helping people see brilliantly. With an over 75-year heritage, we are the largest eye care device company in the world, with complementary businesses in Surgical and Vision Care.
Being a truly global company, we work in 60 countries and serve patients in more than 140 countries. We have a long history of industry firsts, and each year we commit a substantial amount in Research and Development to meet customer needs and patient demands.
AbbVie has dedicated 75+ years to advancing eye care, launching 125+ products for prevalent eye conditions. We continue our commitment to helping ECPs deliver superior patient care through R&D, outreach programs, and educational support.
STAAR Surgical designs, develops, manufactures, markets and implantable lenses for the eye with companion delivery systems. These lenses are intended to provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. More than 2 million lenses have been distributed worldwide.
VSY Biotechnology Gmbh is a progressive and innovative company that focuses on consumer satisfaction by creating superior state-of-the-art ophthalmology and orthopedics products designed and manufactured to greatly enhance and improve vision and comfort for a wide range of patients around the globe.
Product portfolio includes intraocular lenses to treat cataract and refractive errors like presbyopia, astigmatism and ocular problems, as well as injector and cartridge systems , viscoelastics for ophthalmology and orthopedics and hyaluronic acid (HA) viscosupplement products for orthopedics.
Starting from foundation to today, quality and safety standards are the source of our success. We are serving over 80 countries around the globe from our headquarters with a professional marketing and distribution approach.
With our know-how in biotechnology, we will continue to enlighten the world by combining these disciplines for the patients.
The company is owned by Evmann Investments Holding BV at 100%. Evmann Investments Holding BV is a Dutch resident Holding company which currently has investments in ophthalmology and orthopedics industries. Its strategy is to make investments especially in areas creating value for a healthier life under its motto of “Invest for Life”.
As one of the world’s leading medical technology companies, ZEISS Medical Technology is a visionary company at the forefront of healthcare’s digital transformation. ZEISS helps doctors all over the world improve their patients’ lives. With a special focus on ophthalmology, ophthalmic surgery and advanced visualization systems in the field of microsurgery, ZEISS supports healthcare professionals in setting new standards of more personalized, data-driven care with connected workflow solutions and proven diagnostic and treatment technologies based on a long history of cutting-edge innovation.
Bausch + Lomb is a leading global eye care company celebrating 170 years of experience in ophthalmology. Our Surgical Division provides a comprehensive portfolio for anterior, posterior, premium and glaucoma surgery.
The new SeeLuma™ Fully Digital Surgical Visualization Platform is our latest innovation. We also now offer the Minimally Invasive Micro Sclerostomy (MIMS®) surgical procedure for the treatment of glaucoma.
The Stellaris Elite™ vision enhancement system, the LuxSmart™, IC-8® and enVista® premium IOLs, plus the Technolas® TENEO™ 317 M2 Excimer Laser also feature in our range.
Glaukos is an ophthalmic medical technology and pharmaceutical company focused on developing and commercializing novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases.
Rayner is leading the way in ophthalmic innovation with IOLs and ophthalmic solutions designed to provide surgeons and patients with the best visual outcomes. When Sir Harold Ridley designed the world’s first IOL in 1949, he chose Rayner to manufacture this ground-breaking invention.
With more than 70 years of continuous growth and experience, we now sell to over 80 countries. Our mission is to deliver innovative and clinically superior ophthalmic products that consistently respond to the expectations of our global customers and reward the profound trust placed in us to improve sight and quality of life.
Rayner has a broad portfolio of products across the patient pathway, including monofocal and premium Intraocular Lenses (IOLs), a full range of Ophthalmic Viscosurgical Devices (OVDs), a family of Ocular Surface Disease (OSD) solutions and RayPRO, our patient outcomes digital platform.
Rayner is a British company and the only manufacturer of intraocular lenses in the UK.
SCHWIND eye-tech-solutions stands as a pioneer in the refractive market, driving advanced solutions for vision correction procedures and building strong relationships with customers.
The SCHWIND AMARIS excimer and SCHWIND ATOS femtosecond laser systems cover an outstanding broad range of applications, from PRK, TransPRK (i.e. SmartSurfACE), LASEK, FemtoLASIK, PTK, TransPTK, CXL, and keratoplasty with the AMARIS product family to LASIK flap and lenticule extraction (i.e. SmartSight) with the ATOS. Another key differentiator is, that SCHWIND diagnostic devices are seamlessly integrated in the laser environment.